HealthLynked (HLYK)
OTHER OTC:HLYK
Top Page
HealthLynked
(OTC:HLYK)
Select Model
Select Model
Rating:40Underperform
Price Target:
$3.00
â–²(105.48% Upside)
Action:DowngradedDate:04/01/26
The score is primarily driven by very weak financial performance (sharp revenue contraction, persistent losses/cash burn, and a stressed balance sheet with negative equity). Technicals are mixed but not supportive (below key short-term averages with slightly negative MACD), while valuation is constrained by ongoing losses and no dividend. The insider secured convertible financing adds funding/dilution and priority-claim risk.
Positive Factors
Patient-provider connected digital platform
A patient-focused, provider-connected cloud platform aligns with structural healthcare digitization and care coordination trends. Durable value comes from network effects and sticky data assets that can drive recurring revenue and higher lifetime value as adoption by patients and providers grows.
Negative Factors
Negative shareholders' equity
Negative equity reflects accumulated losses and an impaired capital base, reducing financial flexibility. With debt large relative to assets, the company faces elevated refinancing and covenant risk, limiting its ability to invest in growth or weather revenue setbacks.
Read all positive and negative factors
Positive Factors
Negative Factors
Patient-provider connected digital platform
A patient-focused, provider-connected cloud platform aligns with structural healthcare digitization and care coordination trends. Durable value comes from network effects and sticky data assets that can drive recurring revenue and higher lifetime value as adoption by patients and providers grows.
Read all positive factors
HealthLynked (HLYK) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.95M
Dividend YieldN/A
Average Volume (3M)2.50K
Price to Earnings (P/E)―
Beta (1Y)0.95
Revenue Growth-28.51%
EPS Growth38.80%
CountryUS
Employees20
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,941,104
10 Day Avg. Volume3,502
30 Day Avg. Volume2,501
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.69
Price to Sales (P/S)1.92
P/FCF Ratio-2.32
Enterprise Value/Market Cap1.56
Enterprise Value/Revenue7.52
Enterprise Value/Gross Profit7.72
Enterprise Value/Ebitda-7.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HealthLynked Business Overview & Revenue Model
Company Description
HealthLynked (HLYK) is a healthcare technology company focused on creating a patient-centric platform that enhances the delivery and management of healthcare services. The company operates primarily in the health information technology sector, pro...
How the Company Makes Money
null...
HealthLynked Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
9
Very Negative
Cash Flow
12
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.07M | 3.01M | 5.72M | 5.86M | 9.20M |
| Gross Profit | 2.01M | 2.91M | 2.35M | 5.40M | 6.18M |
| EBITDA | -2.13M | -4.36M | -2.75M | -7.05M | -9.85M |
| Net Income | -3.28M | -6.13M | -1.01M | -8.82M | -10.41M |
Balance Sheet | |||||
| Total Assets | 1.70M | 2.22M | 4.28M | 4.58M | 10.69M |
| Cash, Cash Equivalents and Short-Term Investments | 37.14K | 76.24K | 247.22K | 61.89K | 3.29M |
| Total Debt | 5.83M | 997.85K | 1.97M | 1.28M | 978.19K |
| Total Liabilities | 7.46M | 5.35M | 3.48M | 4.27M | 3.49M |
| Stockholders Equity | -5.76M | -3.13M | 804.73K | 314.45K | 7.20M |
Cash Flow | |||||
| Free Cash Flow | -1.71M | -3.50M | -4.15M | -4.39M | -3.79M |
| Operating Cash Flow | -1.71M | -3.49M | -4.14M | -4.36M | -3.77M |
| Investing Cash Flow | 125.00K | 422.40K | 3.51M | -544.75K | -341.36K |
| Financing Cash Flow | 1.55M | 2.90M | 824.09K | 1.68M | 7.24M |
HealthLynked Technical Analysis
Positive
1.46
Price Trends
3.79
Negative
2.98
Positive
2.63
Positive
Market Momentum
-0.09
Positive
48.93
Neutral
63.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLYK, the sentiment is Positive. The current price of 1.46 is below the 20-day moving average (MA) of 3.57, below the 50-day MA of 3.79, and below the 200-day MA of 2.63, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 48.93 is Neutral, neither overbought nor oversold. The STOCH value of 63.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLYK.
HealthLynked Risk Analysis
HealthLynked disclosed 36 risk factors in its most recent earnings report. HealthLynked reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
HealthLynked Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
HealthLynked Corporate Events
Business Operations and StrategyPrivate Placements and Financing
HealthLynked Enters Insider Convertible Note Financing Agreement
Negative
Feb 6, 2026
On February 2, 2026, HealthLynked Corp. issued a $5.72 million senior secured convertible promissory note to the Mary S. Dent Gifting Trust, an entity controlled by CEO and Chairman Dr. Michael Dent, in a related-party transaction that consolidate...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.